NEW YORK (TheStreet) -- Smart Balance (SMBL), Jamba (JMBA), China Marine Food Group (CMFO) and PURE Bioscience (PURE) are four stocks from the consumer non-cyclical industry covering the bioscience and food and beverage industry.

Analysts expect these four stocks to provide attractive investment returns over the next year in the range of 34%-161%, based on the upside implied from their respective 12-month price targets. Additionally, most of these stocks received favorable buy recommendations up to 100%.

In comparison, giants in this sector The Hershey ( HSY), The Coco-Cola ( KO), Unilever ( UL), The Procter & Gamble ( PG) and PepsiCo ( PEP) are expected to return between 5% and 18% over the next 12 months, based on consensus estimates of analysts polled by Bloomberg.

Smart Balance markets functional food products in the U.S. under the Smart Balance and Earth Balance trademarks. The company sells its Smart Balance products in groceries, mass merchandise, and convenience stores. Of the 11 analysts covering the stock, 27% recommend a buy while the remaining suggest a hold. Based on the consensus estimates of analysts polled by Bloomberg, the stock has an implied upside of 34.4% and is currently trading at $4.01.

The company recently reaffirmed its 2010 outlook and estimated net sales to track 2009 levels. Meanwhile, during the fourth quarter, Smart Balance incurred nearly $1 million as organization restructuring charges, which would eventually lead to $1.5 million in annualized savings. Besides, the company has cut its employee strength by almost 12%. Combined, the restructuring activities would lead to a one-time cost of $4 million and accordingly to a corresponding annualized savings of more than $4 million.

Heading into 2011, the company estimates net sales in the mid-single digit percentage range, compared to the 2010 levels. Cash operating income is seen growing in the high single-digit percentage range, compared to 2010. Smart Balance expects its three-tier strategy in the spreads category will enable expansion of its market share in 2011 from 15.3% in 2010. The company is seeking to grow its share in the overall milk category in 2011, after the launch of Fat Free and Lactose Free Plus Calcium milk varieties.

As per analysts at Northland Capital Markets, the company's visibility is gradually improving and is estimated profitable in 2011. Key growth drivers are the reorganization of sales and marketing, organizational restructuring and the company's focus on leveraging the earlier investments. The company intends to focus on promoting the Smart Balance brand, the national launch of Smart Balance milk, and the establishment of a three-tier spreads strategy with the addition of Bestlife spreads, all of which will help it to capitalize on future growth rates.

Jamba is the holding company for its wholly owned subsidiary Jamba Juice Company, owner and franchisor of Jamba Juice Stores. Jamba Juice is a restaurant retailer of food and beverage offerings. Of the 7 analysts covering the stock, 57% recommend a buy while 28% suggest a hold. As per consensus estimates of analysts polled by Bloomberg, the stock has an implied upside of 42.7% and is currently trading at $2.19.

Analysts at Canaccord believe that the company is still in its early stage of transition, which could generate additional rewards for shareholders. Moreover, Canaccord believes that the company's strong brand coupled with a strategic operating model will enable Jamba to transit into an efficient and profitable company.

The company recently reported a marginal growth of 0.2% in company owned comparable net sales during the fourth quarter, compared to the earlier quarter. The first improvement since 2007, this is attributable to the company's 2010 blend plan, marketing initiatives and innovation in menu offerings. Jamba's president and CEO adds that nine license agreements are intact and four Jamba-branded product lines have been commercialized in the retail arena.

Jamba recently launched its first international Jamba Juice location in South Korea's Incheon International Airport, one of the busiest airports in the world, and the primary airport serving the Seoul national capital area. The company believes that this would provide visibility to a large and diverse group of travelers to and from Korea

Heading into 2011, Jamba expects a 2%-4% increase in comparable store sales with an operating profit margin of 18%-20%. The company intends to develop 50-70 locations in traditional, non-traditional, and express formats. After the refranchise of 15 stores in the Denver market, the company has now signed a purchase agreement to refranchise 41 stores in the Chicago/Mid-West market, scheduled for completion during the first quarter of 2011. With this strategy, Jamba hopes to surpass its goal of refranchising 150 stores.

China Marine Food Group engages in the processing, distribution and sale of processed seafood-based snacks and sale of fresh and frozen marine catch. All the three analysts covering the stock recommend a buy. As per the consensus estimates of analysts polled by Bloomberg, the stock has an implied upside of 140.5% and is currently trading at $3.95.

The company recently reported its December 2010 and year-end results for Hi-Power, the marine algae-based beverage. For December 2010, the company's sales were $3.2 million with the addition of 1,000 more retail stores. Meanwhile, for 2010, Hi-Power beverages sales were approximately $26 million, exceeding the company's guidance of $23 to $25 million. Customer orders, both old and new, and brand awareness across 13,000 retail locations where Hi-Power is sold were key growth drivers.

A recent United Nations report reveals global fish consumption has hit record highs, with China, accounting for the majority rise in global per capita consumption. China has benefited from the augment in fish production, pushed by the growth in the aquaculture industry. However, industry analysts reveal almost one-third of the world's fish stocks have to be re-built and irregular fishing be restricted.

PURE Bioscience develops and commercializes bioscience technologies. The company's flagship bioscience technology is an aqueous antimicrobial called silver dihydrogen citrate (SDC). Of the two analysts covering the stock, 50% recommend a buy while the remaining rate holding. As per the consensus estimates of analysts polled by Bloomberg, the stock has an implied upside of 161.2% and is currently trading at $2.01.

Richmont Sciences, PURE's marketing agent, has secured a 10-year, $144 million supply contract from High Scope, a Middle East distributor. The deal's major objective is to bring SDC-based water treatment to the nine Middle East countries. A $355,000 worth product shipment, initially to be used in Dubai as a short trial, launched the 10-year commitment. Meanwhile, High Scope has agreed to buy a minimum $9 million worth SDC in 2011 with annual purchases increasing to $21 million during the tenth year.

The U.S Environmental Protection Agency has approved Pure's SDC as a food-contact surface sanitizer, which opens up new markets. To reduce the threat of bacterial contamination of poultry products, the company is working closely with food microbiologists for testing SDC as a carcass wash. The poultry sector presents a robust growth opportunity and PURE is due to conduct a large study at the University of Georgia, which maintains a facility of almost 9 million chickens.

Griffin Securities estimates the company reporting revenue of $1.9 million in the household product line, $752,000 in personal care and $500,000 in agriculture. Heading into 2012, revenue from these segments is likely to increase more than 90% from the 2011 levels.